DoseSpot Connect
Patient engagement to increase medication affordability and adherence
Platform · Cloud SaaSCompany source
Company profile
About DoseSpot
DoseSpot is a leading certified ePrescribing platform that has been serving healthcare professionals across the spectrum since 2009. The company focuses on delivering simple, affordable, and integrated solutions that enhance the healthcare experience for both patients and providers. DoseSpot's comprehensive platform includes core ePrescribing functionality with electronic prescriptions for controlled substances, DoseSpot Connect for patient engagement and medication affordability, Electronic Prior Authorization (ePA) for streamlined approvals, and Real-Time Prescription Benefit (RTPB) information to address cost barriers to adherence. The platform processes over 50 million prescriptions annually and serves multiple healthcare segments including telehealth and digital health companies, health systems, EHRs/EMRs, provider groups, and dental practices. DoseSpot has recently merged with Arrive Health and pVerify to form Interra Health, creating a unified solution that combines ePrescribing with pharmacy and medical benefits data to advance real-time medication price transparency. The company offers flexible integration options including full customization, plug-and-play interfaces, and standalone solutions, with connections to over 140 APIs. DoseSpot's patient-centric approach puts patients in control of their healthcare decisions by enabling them to find affordable medications and schedule pharmacy pick-ups, ultimately improving engagement, adherence, and outcomes while reducing administrative burden for providers.
Company description DoseSpot official website
Primary marketPharmacy & Medication Management
Commercial modelCommercial information available on request
Company presenceX
Work at DoseSpot?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
No clinical focus areas are currently listed.
Who it serves
- DSO & Dental Practices
- EHRs/EMRs
- Health Systems
- Provider Groups
- Telehealth & Digital Health
Deployment & integration
Cloud Saas deployment with recorded integration context.
Recorded integration context: 140+ APIs, EHR/EMR systems, Major prior authorization networks.
Geographic context
MarketsIndia · United States
Company sourceOfficial website
Company milestones
Platform expansion
Merged with Arrive Health and pVerify to form Interra Health, combining ePrescribing platform with medical and pharmacy benefits data for real-time medication price transparency
Partnerships
Recorded partners
- Arrive Health (merged)
- ChatRx
- DialCare
- pVerify (merged)
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
DoseSpot ePrescribing
Certified ePrescribing platform with functionality, flexibility and compliance
Platform · Cloud SaaSCompany source
Electronic Prior Authorization
Reduce administrative burden and improve the speed to therapy
Software · Cloud SaaSCompany source
Full Integration
A fully customizable, cloud-based integration
Api · Cloud SaaSCompany source
Jumpstart
A plug-and-play user interface
Software · Cloud SaaSCompany source
Real-Time Prescription Benefit (RTPB)
In-workflow patient-specific prescription benefit information
Software · Cloud SaaSCompany source
TreatRx
Simple, affordable and standalone ePrescribing
Software · Cloud SaaSCompany source
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
No linked records are currently available.
Clinical validation
Clinical-trial records
No linked records are currently available.
Regulatory
Regulatory records
No linked records are currently available.
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
50M+ prescriptions processed annually
Platform volume based on internal DoseSpot data
75% reduction in prescribing time
DialCare case study
Improved medication adherence
Through patient engagement and cost transparency
Reduced treatment delays
Via electronic prior authorization
ChatRx
Scaled prescribing speed, reduced prescribing time, eliminated prescription failures, and built faster path to affordable physician-governed telemedicine
Reduced prescribing time and eliminated prescription failures
DialCare
Modernized ePrescribing experience as part of major platform rebuild to improve efficiency, reduce friction, and support rapid growth
75% reduction in prescribing time
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
06 · Company updates
Updates from DoseSpot
Recent articles published on DoseSpot's official website.
No Company updates are currently listed.
07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Pharmacy & Medication Management
Companies using AI for medication optimization, pharmacy automation, drug pricing and access, medication adherence, polypharmacy management, or pharmacy workflow optimization. Includes platforms that help patients access affordable medications, tools that reduce medication errors, and AI systems that optimize drug regimens for complex patients.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market
10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.